Resources
The latest in drug discovery, from novel targets and screening tools through to automation and computational chemistry
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Target Based Discovery
Navigating DEL Screening from Hit to Lead
The panel at Drug Discovery US discussed hit finding technologies, protein availability for screening, and hit-to-lead transition.
Neuroscience Discovery
Challenges in Developing Organoids for Neuroscience
Oxford Global’s panel discussion: Translational Models from 3D to Animal Model of Disease – Neuroscience, asked experts to share their experience of developing organoids for translational neuroscience.
Organ Modelling Discovery
Cultrex™ Extracellular Matrix And Proteins
CultrexTM Basement Membrane Extract (BME)
Neuroscience Discovery
Prothena and Evotec Score Major Deals with Bristol Myers Squibb for Neuroscience Breakthroughs
Prothena will receive $55 million to license its clinical Alzheimer's drug candidate, while Evotec will receive $40 million for its late-stage clinical programs.
Pharma Data
A Guide to Successful Real World Evidence Implementation
How can you overcome challenges and unleash the potential of Real-World Evidence for impactful healthcare insights?
Organ Modelling Discovery
Scientists Create Transparent Mouse to Advance Preclinical Medicine
The method, known as tissue clearing and immunolabeling, enables the detection of tumours at the single-cell level.
AI, Machine Learning & Computational Drug Design
What is AlphaFold?
AlphaFold is the protein folding solution that took computational biology by storm, but has the protein folding problem been well and truly solved?
Organ Modelling Discovery
Newcells Products and Services
We build custom, functional in vitro models, mimicking in vivo physiology, to improve clinical translation and accelerate drug discovery
Targeted Protein Degradation
Interview with Yusuke Tominari, Co founder and CEO of Fimecs
Yusuke will be giving a keynote presentation at Discovery Europe 2023 titled 'Targeted Protein Degradation And Addressing Undruggable Targets'.
Target Based Discovery
Tailor-made ADME-Tox
Admescope is a contract research organisation (CRO) providing the pharmaceutical industry with tailor-made ADME-Tox services to support the discovery and development of small molecules and biologics.
Organ Modelling Discovery
Cultrex™ Products for Physiologic Cell Culture
R&D Systems products for physiologic cell culture recreate tissue microenvironments to elicit in vivo structure and function for cells in vitro.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery